Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Activation or exhaustion of CD8+ T cells in patients with COVID-19
Min‐Seok Rha, Eui‐Cheol Shin
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 10, pp. 2325-2333
Open Access | Times Cited: 164

Showing 26-50 of 164 citing articles:

T Cell Exhaustion in Allergic Diseases and Allergen Immunotherapy: A Novel Biomarker?
Qingxiu Xu, Le Li, Rongfei Zhu
Current Allergy and Asthma Reports (2025) Vol. 25, Iss. 1
Closed Access
Cellular Senescence in Immunity against Infections
Veronica Marrella, Amanda Facoetti, Barbara Cassani
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11845-11845
Open Access | Times Cited: 26
Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-19
Weng Hua Khoo, Katherine Jackson, Chansavath Phetsouphanh, et al.
Clinical Immunology (2022) Vol. 246, pp. 109209-109209
Open Access | Times Cited: 25
Ketone Bodies Improve Human CD8+ Cytotoxic T-Cell Immune Response During COVID-19 Infection
Simon Hirschberger, Luca Maximilian Gellert, David Effinger, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 22
Emerging roles of SARS-CoV-2 Spike-ACE2 in immune evasion and pathogenesis
Cosima T. Baldari, Anna Onnis, Emanuele Andreano, et al.
Trends in Immunology (2023) Vol. 44, Iss. 6, pp. 424-434
Open Access | Times Cited: 14
Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2
Prabhat Kumar Purbey, Koushik Roy, Sandeep Gupta, et al.
Molecular Immunology (2023) Vol. 156, pp. 111-126
Open Access | Times Cited: 13
The unreversible reduced but persistent activated NK and CD8 + T cells in severe/critical COVID-19 during omicron pandemic in China
Ling Qin, Xinmin Duan, Jay Zengjun Dong, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 12
The gut microbe pair of Oribacterium sp. GMB0313 and Ruminococcus sp. GMB0270 confers complete protection against SARS-CoV-2 infection by activating CD8+ T cell-mediated immunity
Mingda Wang, Enkhchimeg Lkhagva, Sura Kim, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
SARS-CoV-2 breakthrough infections enhance T cell response magnitude, breadth, and epitope repertoire
Alison Tarke, Parham Ramezani-Rad, Tertuliano Alves Pereira Neto, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 6, pp. 101583-101583
Open Access | Times Cited: 4
Enhancing cross-protection against influenza by heterologous sequential immunization with mRNA LNP and protein nanoparticle vaccines
Chunhong Dong, Wandi S. Zhu, Lai Wei, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
CD4 + and CD8 + T cells are required to prevent SARS-CoV-2 persistence in the nasal compartment
Meenakshi Kar, Katherine Johnson, Abigail Vanderheiden, et al.
Science Advances (2024) Vol. 10, Iss. 34
Open Access | Times Cited: 4
COVID‐19 immunopathology with emphasis on Th17 response and cell‐based immunomodulation therapy: Potential targets and challenges
Arash Pourgholaminejad, Saghar Pahlavanneshan, Mohsen Basiri
Scandinavian Journal of Immunology (2021) Vol. 95, Iss. 2
Closed Access | Times Cited: 27
Immune responses to SARS-CoV-2 in dialysis and kidney transplantation
Chiara Cantarelli, Andrea Angeletti, Laura Perin, et al.
Clinical Kidney Journal (2022) Vol. 15, Iss. 10, pp. 1816-1828
Open Access | Times Cited: 21
New insights into extracellular and intracellular redox status in COVID-19 patients
Mohammad Javad Tavassolifar, Hamid Asadzadeh Aghdaei, Omid Sadatpour, et al.
Redox Biology (2022) Vol. 59, pp. 102563-102563
Open Access | Times Cited: 20
COVID‐19 plasma proteome reveals novel temporal and cell‐specific signatures for disease severity and high‐precision disease management
Cristiana Iosef, Claudio M. Martin, Marat Slessarev, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 27, Iss. 1, pp. 141-157
Open Access | Times Cited: 19
Disease Severity in Moderate-to-Severe COVID-19 Is Associated With Platelet Hyperreactivity and Innate Immune Activation
Kai Jakobs, Leander Reinshagen, Marianna Puccini, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
The HDAC inhibitor zabadinostat is a systemic regulator of adaptive immunity
Geng Liu, Wojciech Barczak, Lian Ni Lee, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 11
A prospective study of cellular immune response to booster COVID-19 vaccination in multiple sclerosis patients treated with a broad spectrum of disease-modifying therapies
Pascual Torres, A. Sancho-Saldaña, Anna Gil-Sánchez, et al.
Journal of Neurology (2023) Vol. 270, Iss. 5, pp. 2380-2391
Open Access | Times Cited: 11
The role of Bach2 in regulating CD8 + T cell development and function
Xinyu Weng, Min Zheng, Yanning Liu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Immune checkpoint inhibitors and SARS-CoV2 infection
Samaneh Abdolmohammadi‐Vahid, Behzad Baradaran, Ian M. Adcock, et al.
International Immunopharmacology (2024) Vol. 137, pp. 112419-112419
Closed Access | Times Cited: 3
Superantigens and SARS-CoV-2
Adam Hamdy, Anthony Leonardi
Pathogens (2022) Vol. 11, Iss. 4, pp. 390-390
Open Access | Times Cited: 16
The deciphering of the immune cells and marker signature in COVID‐19 pathogenesis: An update
Saade Abdalkareem Jasim, Roaa Salih Mahdi, Dmitry Olegovich Bokov, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 11, pp. 5128-5148
Open Access | Times Cited: 16
Emerging Effects of IL-33 on COVID-19
Yuan Gao, Luwei Cai, Lili Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13656-13656
Open Access | Times Cited: 16
Multiplex sensing of IL-10 and CRP towards predicting critical illness in COVID-19 infections
Sasya Madhurantakam, Zachary Lee, Aliya Naqvi, et al.
Biosensors and Bioelectronics X (2023) Vol. 13, pp. 100307-100307
Open Access | Times Cited: 9
Potential Immune Indicators for Predicting the Prognosis of COVID-19 and Trauma: Similarities and Disparities
Hamed Fouladseresht, Atefe Ghamar Talepoor, Nahid Eskandari, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 15

Scroll to top